XML 111 R97.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity - Deferred Compensation (Details) - USD ($)
$ in Millions
1 Months Ended 12 Months Ended
Jul. 31, 2021
Apr. 30, 2021
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Employee Compensation And Benefits                
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]                
Share-based compensation expense     $ 14.2 $ 14.2 $ 9.3      
Selling and Administrative Expense                
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]                
Share-based compensation expense     $ 0.7 $ 0.8 $ 0.6      
Chief Executive Officer | Common Stock                
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]                
Restricted stock vested during period, net settled (in shares)     153,287 120,665 150,530      
Chief Executive Officer | ACM Acquisition | Common Stock                
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]                
Restricted stock vested during period, net settled (in shares)     172,513 186,772 229,083      
Restricted Common Stock                
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]                
Total grant date fair value     $ 23.7 $ 21.3        
Restricted stock vested with grant date fair value (in shares)     874,611          
Restricted stock vested during the period, grant date fair value     $ 11.1          
Unvested restricted common stock outstanding (in shares)     1,657,078 1,389,427        
Unrecognized compensation cost     $ 8.1          
Remaining weighted-average vesting period     1 year 9 months 18 days          
Restricted Common Stock | 2020 Plan | Chief Executive Officer                
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]                
Grants during the period (in shares)     247,275          
Total grant date fair value     $ 2.9          
Restricted Common Stock | Employees                
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]                
Grants during the period (in shares)       652,596        
Total grant date fair value       $ 11.1        
Restricted Common Stock | Employees | 2020 Plan                
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]                
Grants during the period (in shares)     943,788   384,758      
Total grant date fair value     $ 11.3   $ 6.4      
Restricted Common Stock | Employees | 2020 Plan | Vested on Grant Date                
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]                
Grants during the period (in shares)     299,710 232,899 144,951      
Total grant date fair value     $ 3.6 $ 4.0 $ 2.4      
Restricted Common Stock | Employees | 2020 Plan | First Anniversaries                
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]                
Grants during the period (in shares)     277,751   101,475      
Total grant date fair value     $ 3.4 $ 3.7 $ 1.7      
Restricted Common Stock | Employees | 2020 Plan | Second Anniversaries                
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]                
Grants during the period (in shares)     253,479 181,968 88,788      
Total grant date fair value     $ 3.0 $ 3.1 $ 1.5      
Restricted Common Stock | Employees | 2020 Plan | Third anniversaries                
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]                
Grants during the period (in shares)     78,126 9,951 25,479      
Total grant date fair value     $ 0.9 $ 0.2 $ 0.4      
Restricted Common Stock | Employees | 2020 Plan | Fourth Anniversaries                
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]                
Grants during the period (in shares)     34,722 9,938 24,065      
Total grant date fair value     $ 0.4 $ 0.2 $ 0.4      
RSUs | 2020 Plan | Director                
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]                
Grants during the period (in shares)     40,796 25,012        
Total grant date fair value     $ 0.5 $ 0.4        
RSUs | 2020 Plan | Chief Executive Officer                
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]                
Grants during the period (in shares)       189,873        
Total grant date fair value       $ 3.3        
RSUs | Employees | First Anniversaries                
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]                
Grants during the period (in shares)       217,840        
Time Based Vesting Equity Award | Chief Executive Officer                
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]                
Grants during the period (in shares) 165,746 184,729            
Total grant date fair value $ 3.0 $ 3.1            
Performance-Based Restricted Stock | Chief Executive Officer                
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]                
Grants during the period (in shares)     352,427         294,985
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period       381,503 448,980      
Vesting period (in years)     4 years 4 years        
Performance-Based Restricted Stock | Chief Executive Officer | ACM Acquisition                
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]                
Grants during the period (in shares)           313,152 246,508 294,985